PharmaEssentia Corporation
6446
Clasificación en acciones
#1413
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Precio por acción
$37.84
Capitalización bursátil
$15.65B
Cambio (1 día)
3.03%
Cambio (1 año)
148.76%
País
TW
Comercio PharmaEssentia Corporation (6446)
Categoría
Healthcare
Número de acciones en circulación de PharmaEssentia Corporation (6446)
Número de acciones en circulación al June 2026: 504.54M
Según los últimos informes financieros y el precio de las acciones de PharmaEssentia Corporation, el número actual de acciones en circulación es 504.54M. Al final de December 2023, la empresa tenía 357.63M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de PharmaEssentia Corporation (6446) desde 2010 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 504.54M | 39.70% |
| 2024 | 361.15M | 0.98% |
| 2023 | 357.63M | 13.47% |
| 2022 | 315.19M | 9.24% |
| 2021 | 288.52M | 6.05% |
| 2020 | 272.06M | 11.95% |
| 2019 | 243.02M | -2.49% |
| 2018 | 249.23M | 0.35% |
| 2017 | 248.36M | 6.59% |
| 2016 | 233.00M | 7.71% |
| 2015 | 216.33M | 0.61% |
| 2014 | 215.01M | 7.64% |
| 2013 | 199.75M | 37.81% |
| 2012 | 144.95M | 4.85% |
| 2011 | 138.25M | 0.00% |
| 2010 | 138.25M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 375.55% |
IN
|
